Kata Horváti

1.2k total citations
52 papers, 944 citations indexed

About

Kata Horváti is a scholar working on Molecular Biology, Microbiology and Infectious Diseases. According to data from OpenAlex, Kata Horváti has authored 52 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 15 papers in Microbiology and 10 papers in Infectious Diseases. Recurrent topics in Kata Horváti's work include Antimicrobial Peptides and Activities (15 papers), Chemical Synthesis and Analysis (11 papers) and Tuberculosis Research and Epidemiology (10 papers). Kata Horváti is often cited by papers focused on Antimicrobial Peptides and Activities (15 papers), Chemical Synthesis and Analysis (11 papers) and Tuberculosis Research and Epidemiology (10 papers). Kata Horváti collaborates with scholars based in Hungary, Czechia and Austria. Kata Horváti's co-authors include Szilvia Bősze, Bernadett Bacsa, C. Oliver Kappe, Fritz Andreae, Ferenc Hudecz, Éva Kiss, Gergő Gyulai, Jarmila Vinšová, Jiřina Stolaříková and Nóra Szabó and has published in prestigious journals such as Nature Communications, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Kata Horváti

49 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kata Horváti Hungary 18 578 300 161 151 87 52 944
Martijn Risseeuw Belgium 22 844 1.5× 544 1.8× 74 0.5× 115 0.8× 113 1.3× 62 1.3k
Rainer Riedl Switzerland 18 578 1.0× 255 0.8× 85 0.5× 93 0.6× 47 0.5× 49 1.2k
Jarbas M. Resende Brazil 20 613 1.1× 248 0.8× 456 2.8× 42 0.3× 99 1.1× 53 1.2k
Gunnar T. Dolphin Sweden 16 442 0.8× 152 0.5× 91 0.6× 43 0.3× 94 1.1× 24 706
Yingjie Wang China 19 622 1.1× 102 0.3× 124 0.8× 290 1.9× 22 0.3× 53 1.2k
Elizabeth Fullam United Kingdom 20 543 0.9× 208 0.7× 55 0.3× 256 1.7× 44 0.5× 43 995
M. Daben J. Libardo United States 14 438 0.8× 124 0.4× 328 2.0× 119 0.8× 22 0.3× 21 751
Brian L. Bray United States 13 591 1.0× 596 2.0× 112 0.7× 61 0.4× 28 0.3× 22 1.1k
Kasper K. Sørensen Denmark 16 595 1.0× 323 1.1× 113 0.7× 25 0.2× 160 1.8× 44 926

Countries citing papers authored by Kata Horváti

Since Specialization
Citations

This map shows the geographic impact of Kata Horváti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kata Horváti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kata Horváti more than expected).

Fields of papers citing papers by Kata Horváti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kata Horváti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kata Horváti. The network helps show where Kata Horváti may publish in the future.

Co-authorship network of co-authors of Kata Horváti

This figure shows the co-authorship network connecting the top 25 collaborators of Kata Horváti. A scholar is included among the top collaborators of Kata Horváti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kata Horváti. Kata Horváti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wacha, András, Imola Cs. Szigyártó, Andrea Bodor, et al.. (2024). In situ captured antibacterial action of membrane-incising peptide lamellae. Nature Communications. 15(1). 3424–3424. 12 indexed citations
2.
Horváti, Kata, et al.. (2024). Bidirectional Allosteric Coupling between PIP2 Binding and the Pore of the Oncochannel TRPV6. International Journal of Molecular Sciences. 25(1). 618–618. 1 indexed citations
3.
Fodor, Kinga, Szilvia Bősze, Bernadett Bacsa, et al.. (2023). Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection. Bioconjugate Chemistry. 34(10). 1738–1753. 2 indexed citations
4.
Tóth, Gergő, Zoltán Mucsi, Kata Horváti, et al.. (2021). Tissue-Specific Accumulation and Isomerization of Valuable Phenylethanoid Glycosides from Plantago and Forsythia Plants. International Journal of Molecular Sciences. 22(8). 3880–3880. 4 indexed citations
5.
Voszka, István, et al.. (2021). Comparison of the Efficacy of Two Novel Antitubercular Agents in Free and Liposome-Encapsulated Formulations. International Journal of Molecular Sciences. 22(5). 2457–2457. 10 indexed citations
6.
Juhász, Tünde, Kata Horváti, Szilvia Bősze, et al.. (2020). Old Polyanionic Drug Suramin Suppresses Detrimental Cytotoxicity of the Host Defense Peptide LL-37. ACS Pharmacology & Translational Science. 4(1). 155–167. 8 indexed citations
7.
Horváti, Kata, Szilvia Bősze, Beáta Biri‐Kovács, et al.. (2020). Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides. International Journal of Molecular Sciences. 21(6). 2197–2197. 4 indexed citations
8.
Tóth, Gergő, Márta Kraszni, Zoltán Mucsi, et al.. (2019). Galls of European Fraxinus trees as new and abundant sources of valuable phenylethanoid and coumarin glycosides. Industrial Crops and Products. 139. 111517–111517. 11 indexed citations
9.
Juhász, Tünde, Judith Mihály, Imola Cs. Szigyártó, et al.. (2019). Manipulating Active Structure and Function of Cationic Antimicrobial Peptide CM15 with the Polysulfonated Drug Suramin: A Step Closer to in Vivo Complexity. ChemBioChem. 20(12). 1578–1590. 23 indexed citations
10.
Horváti, Kata, Gergő Gyulai, Antal Csámpai, et al.. (2018). Surface Layer Modification of Poly(d,l-lactic-co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127–Tuftsin Conjugate. Bioconjugate Chemistry. 29(5). 1495–1499. 23 indexed citations
12.
Ábrányi‐Balogh, Péter, László Petri, Tı́mea Imre, et al.. (2018). A road map for prioritizing warheads for cysteine targeting covalent inhibitors. European Journal of Medicinal Chemistry. 160. 94–107. 90 indexed citations
13.
Zsila, Ferenc, Szilvia Bősze, Kata Horváti, Imola Cs. Szigyártó, & Tamás Beke‐Somfai. (2017). Drug and dye binding induced folding of the intrinsically disordered antimicrobial peptide CM15. RSC Advances. 7(65). 41091–41097. 17 indexed citations
14.
Horváti, Kata, Bernadett Bacsa, Nóra Szabó, et al.. (2017). Comparative analysis of internalisation, haemolytic, cytotoxic and antibacterial effect of membrane-active cationic peptides: aspects of experimental setup. Amino Acids. 49(6). 1053–1067. 31 indexed citations
15.
Horváti, Kata, et al.. (2016). Investigation of Encapsulated Liposomal Antituberculotics and Effects on in Vitro Model Systems. Biophysical Journal. 110(3). 246a–247a. 1 indexed citations
16.
Baranyai, Zsuzsa, et al.. (2016). Comparative analysis of new peptide conjugates of antitubercular drug candidates—Model membrane and in vitro studies. Colloids and Surfaces B Biointerfaces. 147. 106–115. 7 indexed citations
17.
Horváti, Kata, Bernadett Bacsa, Nóra Szabó, et al.. (2015). Antimycobacterial activity of peptide conjugate of pyridopyrimidine derivative against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Tuberculosis. 95. S207–S211. 25 indexed citations
18.
Vavříková, Eva, Slovenko Polanc, Marijan Kočevar, et al.. (2011). New series of isoniazid hydrazones linked with electron-withdrawing substituents. European Journal of Medicinal Chemistry. 46(12). 5902–5909. 38 indexed citations
19.
Krátký, Martin, Jarmila Vinšová, Vladimı́r Buchta, et al.. (2010). New amino acid esters of salicylanilides active against MDR-TB and other microbes. European Journal of Medicinal Chemistry. 45(12). 6106–6113. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026